Skip to content
Clinical Trials – home

Justus-Liebig-Universitaet Giessen

Verifiedinfo

Germany Klinikstrasse 33, 35392 Giessen, Germany

  • 126 trials recruiting
  • Non-small cell lung cancer · Pulmonary arterial hypertension · Non-small cell lung cancer metastatic
  • Adults and children

About Specializations

Justus-Liebig-Universitaet Giessen in Giessen, Germany specialises in clinical trials of conditions such as Non-small cell lung cancer, Pulmonary arterial hypertension, Non-small cell lung cancer metastatic, Squamous cell carcinoma of head and neck, and other specialisations. This site conducts important research.

Main research areas of the site

Eye Diseases Research

The clinical trial activity at Justus-Liebig-Universitaet Giessen focuses on eye diseases, with studies centered on conditions that can seriously affect vision and daily life. The main research interests include geographic atrophy and macular edema due to central retinal vein occlusion, reflecting a strong commitment to improving care in retinal disease.

  • Evaluation of new approaches for geographic atrophy linked to age-related macular degeneration
  • Assessment of treatments for macular edema caused by central retinal vein occlusion
  • Research aimed at testing whether vision-related disease progression can be slowed or better controlled
  • Clinical work focused on improving treatment effectiveness and long-term patient outcomes in retinal disorders

These trials bring together a large investigator team and a clear ophthalmology focus, supporting research that explores both novel therapy options and ways to optimize existing treatment strategies.

Retinal Disease Studies

At the Klinik und Poliklinik für Augenheilkunde, current research is directed toward retinal conditions that can lead to progressive visual impairment. The studies are designed to examine whether new treatment strategies can better address geographic atrophy and improve management of macular edema due to central retinal vein occlusion.

  • Investigation of therapies for retinal degeneration in geographic atrophy
  • Testing treatment options for swelling and fluid-related vision problems in central retinal vein occlusion
  • Work focused on reducing disease burden and preserving sight over time
  • Clinical evaluation of strategies intended to improve the durability of eye care treatments

The site’s research profile highlights a practical interest in both innovative treatment development and the refinement of established ophthalmic care for patients with chronic retinal disease.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Klinikstrasse 3335392 GiessenGermany
Recruiting now
126 trials
Conditions studied
173
Partner status
Verified

More sites in GiessenGermany

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

273 clinical trials

Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:LUNSEKIMIG
  • Sponsor:Sanofi-Aventis Recherche & Developpement
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Depemokimab
  • Sponsor:Glaxosmithkline Research & Development Limited
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Loratadine
  • Sponsor:Pfizer Inc.
Countries:GermanyGermany
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Duvakitug
  • Sponsor:Sanofi-Aventis Recherche & Developpement
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:AstraZeneca AB
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Everolimus
  • Sponsor:Exelixis Inc.
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Depemokimab
  • Sponsor:Glaxosmithkline Research & Development Limited
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Prax-628
  • Sponsor:Praxis Precision Medicines Inc.
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Sponsor:AstraZeneca AB
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Colchicine
  • Sponsor:Medical University Of Graz
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:BNT327
  • Sponsor:BioNTech SE
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Tozorakimab
  • Sponsor:AstraZeneca AB
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.